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Solid state fermentationAbstract The present investigation, focused on screening of various fungal species for Lovastatin
production using different agro-based wastes, also, for maximizing lovastatin productivity by iso-
lated Aspergillus fumigatus using response surface methodology (RSM). The following substrates
(Olive cake; Pea pods; sugarcane bagasse; wheat bran; rice hulls; beet peel; Potato peel and ground-
nut shells) were screened to evaluate their effectiveness for lovastatin production, using different
fungal species, (Aspergillus niger; Rhizopus oligosporus; Penicillium citrinum and isolated Aspergillus
fumigatus) under solid state fermentation (SSF). Wheat bran was the most suitable substrate for
lovastatin production with all fungal species. Optimum conditions of lovastatin production by
wheat bran have been attained efficiently by response surface methodology (RSM) using isolated
Aspergillus fumigatus under solid state fermentation (SSF). The lovastatin yield of (3.353 mg/g
DFM) was obtained at an optimum temperature of 28 C; pH of 5.00; initial moisture content of
70% and incubation period of 12 days. This Lovastatin has the possibility to use in different ther-
apeutic applications.
 2016 Production and hosting by Elsevier B.V. on behalf of Academy of Scientific Research &
Technology. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).1. Introduction
Lovastatin is produced as a secondary metabolite of the
polyketide pathway by various fungi including Penicillium
spp. [5];Monascus spp. [12]; Trichoderma spp. [4] and Aspergil-
lus terreus [8]. A. terreus is known to be the best lovastatin-
producing species [23]. Statins (e.g. lovastatin) are fungal sec-
ondary metabolites, also considered a group of medicallyimportant inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme
A (HMG-CoA reductase), which catalyzes the rate limiting
step of cholesterol biosynthesis [19,22]. Clinically, statins are
used as lipid-lowering drugs that effectively lower LDL-
cholesterol levels and reduce the risk of cardiovascular events
in dyslipidemic patients [3,10]. It decreases LDL level more
than other cholesterol lowering drugs, [13]. Lovastatin does
not only find a role as anti-cholesterol agent but also plays a
key role as an anti-inflammatory agent; cancer cell apoptosis;
renal function restoration; treatment for bone disorders and
suppressed production of tumor necrosis factor [19]. There is
also an increased interest in statins non-lipid activities such
Figure 1 Screening for lovastatin production using different
agro-based waste.
254 F.E. Mouafi et al.as, protection of host cellular damage [27]. In addition, lovas-
tatin has been used in the biomedical applications such as
treating coronary heart diseases; Alzheimer’s disease [25].
For statin production an alternative strategy for submerged
fermentation is the solid state fermentation process (SSF),
where solid state fermentation is more advantageous, which
offers a good environment for fungi to grow, therefore high
mycelia density and high lovastatin production can be
expected [19]. According to Pandey et al. [16] solid state fer-
mentation is a process where a wide range of agricultural
wastes can be used for growing fungal species and to minimize
the overall valuable product cost. Also, it eases optimization
parameters, as it involves lower media cost; stability of the
product; increased yield and better substrate porosity [2,21].
The present study aims to optimize and demonstrate the effect
of different factors and factor–factor interactions on Lovas-
tatin production by isolated Aspergillus fumigatus using
response surface methodology (RSM) under solid state
fermentation.
2. Materials and methods
2.1. Organisms
Different fungal species were selected for the production of
Lovastatin using solid state fermentation (Aspergillus niger
NRRL 595; Rhizopus oligosporus NRRL 2710 and Penicillium
citrinum). The three strains were purchased from NRRL:
Northern Regional Research Laboratory, United States
Department of Agriculture, Peoria Illinois, USA. In addition,
twenty-two fungal isolates were purified from mangrove tree
sediments grown along the shores of Red sea, Makadi village,
Hurghada region, Egypt.
2.2. Identification of the most efficient lovastatin producer
isolate
The most potent fungal strain, isolated from (mangrove trees
sediments grown along shores of Red sea, Makadi village,
Hurghada region, Egypt) was identified by its morphological
and conidial features in the culture growth and DNA partial
sequencing. DNA sequencing of the most potent fungal strain
was carried out with PCR amplicon. The 28S r DNA sequence
D1/D2 region was amplified by PCR from fungal genomic
DNA using PCR universal primers:
DR-50-GGTCCGTGTTTCAAGACGG-30 and DF-50-AC
CCGCTGAACTTAAGC-30 respectively, where it has been
identified as Aspergillus fumigatus (Fig. 1). Identification has
been performed at Macrogen Company, Korea.
2.3. Culture maintenance and inoculum preparation
Cultures of all tested fungi were maintained on potato dextrose
agar (PDA) at 28 C for 10 days. Spores that formed were then
scrapped and suspended in sterile dist. Water with 0.1% (v/v)
Tween 80 and vigorously shaken for 1 min, 2 mL spore suspen-
sions were used as the inoculums for the present investigation
[20].2.4. Culture preparations and conditions
Eight agro-wastes (Olive cake; Pea pods; sugarcane bagasse;
wheat bran; rice hulls; beet peel; Potato peel and groundnut
shells) were dried at 70 C for 24 h., cooled and grounded.
Ten grams of each solid substrates was taken separately in
250 mL Erlenmeyer’s flasks and was moistened with distilled
water containing (MgSO47H2O (0.15 g/l); (NH4)2HPO4
(0.25 g/l); NaCl (1 g/l) to maintain the moisture content of
70% (v/w) [9]. Then, substrates were autoclaved at 121 C
for 20 min, cooled to room temperature and flasks were inoc-
ulated with 2 mL of fungal spore suspension. The contents in
the flask were mixed thoroughly to ensure uniform distribution
of the inoculum and flasks were incubated at 28 C for 10 days
[6].
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At the end of SSF, lovastatin concentration was analyzed,
where the fermented material was dried at 60 C for 24 h, pow-
dered, and 4 g of the powdered material was extracted with
ethyl acetate (pH 3.0) in 250 mL Erlenmeyer’s flasks. It was
then, incubated at 28 C in rotary shaker at 200 rpm for 2 h.
Then the mixture was centrifuged at 1500 rpm for 20 min. Fil-
tration was done using Whatman filter paper No. 1 for separa-
tion of fungal cell biomass from the filtrate. The supernatant
was stored in glass bottles at 4 C until used for further anal-
ysis [20]. To 1 mL of the supernatant; 1 mL of acetic acid
(1%) was added and incubated for 10 min. From the above
solution, 1 mL was taken and diluted 10 times with methanol,
and its absorbance was read at 238 nm, using UV–Visible spec-
trophotometer [11].
Concentration of Lovastatin ðmg=gÞ
¼ ðConcentration of Lovastatin ðmg=mlÞ
Amoun t of substrate ðWheat branÞ taken ðgÞ
Dilution factor2.6. Design of experiment (DOE)
Response surface method; central composite design (CCD)
model (Table 1); based on four factors and five levels was used
to study the effect and interactions between temperature (A) in
the range between 24 and 40 C; pH (B) in the range between 4
and 8; moisture content (C) in the range between 40% and
80%, and incubation period (D) in the range between 3 and
15 days for maximum lovastatin production by AspergillusTable 1 Central composite design (CCD) used for optimization of
Run number Temperature (C) pH
1–3 28 5
4–6 36 5
7–9 28 7
10–12 36 7
13–15 28 5
16–18 36 5
19–21 28 7
22–24 36 7
25–27 28 5
28–30 36 5
31–33 28 7
34–36 36 7
37–39 28 5
40–42 36 5
43–45 28 7
46–48 36 7
49–51 24 6
52–54 40 6
55–57 32 4
58–60 32 8
61–63 32 6
64–66 32 6
67–69 32 6
70–72 32 6
73–75 32 6
76–78 32 6fumigatus. Experimental designs were performed using
Design-Expert software (Stat-Ease Inc., Minneapolis, MN,
USA, ver 7.0.0). Experiments were performed in triplicates
with six central points. A total of 78 runs were employed in
CCD to estimate curvature and interaction effects of selected
variables, and finally, significance of the obtained model was
checked by F-test (calculated p-value) and goodness of fit by
multiple correlation R as well as determination R2 coefficients.
Lovastatin concentration (mg/g) was the measured experimen-
tal response.
Statistical Analysis: Analysis of variance (ANOVA) was
used to estimate the statistical parameters for optimization
of culture conditions. A probability value of P value <0.05
was used as the criterion for statistical significance.
3. Results and discussion
3.1. Screening of different agro based wastes for lovastatin
production using several fungal species by solid state
fermentation
Table 2 and Fig. 1 showed that, among all screened fermented
substrates with different fungal strains, wheat bran has topped
the list with a maximum lovastatin yield, where the yield was
2.84; 2.69; 2.53 and 1.84 mg/g of dried fermented matter
(DFM) by A. fumigatus; A. niger; Penicillium citrinum and Rhi-
zopus oligosporus. This result is in accordance with [18,22,14,7]
and Raghunath et al. [20] who, also found wheat bran to be a
suitable substrate for lovastatin production. On other hand,
sugar cane bagasse; olive cake and potato peel also yielded
good amount of lovastatin by all different fungal strains.
2.41, 2.28 and 2.25 mg/g dry fermented matter, by A. nigerlovastatin production (organized in triplicate runs).
Moisture Content (%) Incubation period (Days)
50 6
50 6
50 6
50 6
70 6
70 6
70 6
70 6
50 12
50 12
50 12
50 12
70 12
70 12
70 12
70 12
60 9
60 9
60 9
60 9
40 9
80 9
60 3
60 15
60 9
60 9
Table 2 Screening for lovastatin production using different agro-based waste.
Lovastatin concentration (mg/g) Aspergillus fumigatus Aspergillus niger Penicillium citrinum Rhizopus oligosporus
Wheat bran 2.84 2.69 2.53 1.84
Olive cake 2.28 2.12 1.94 1.78
Beet peel 1.75 1.63 1.28 1.81
Groundnut shell 1.94 1.38 1.31 0.69
Pea pods 1.13 1.59 1.22 1.03
Potato peel 2.25 2.03 1.38 0.78
Bagasse 2.41 2 1.56 0.88
Rice hulls 1.75 1.19 0.78 0.56
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Figure 2 Phylogenetic tree based on rDNA gene sequencing, showing the phylogenetic relationship of Aspergillus fumigatus within
representative species of the genus Aspergillus.
Table 3 Analysis of variance (ANOVA) results for Lovastatin central composite design.
Source Sum of Squares df Mean square F-Value p-value (Prob > F)*
Model 56.97 12 4.747 36.479 <0.0001
A-Temperature 19.66 1 19.662 151.080 <0.0001
B-pH 7.58 1 7.576 58.212 <0.0001
C-Moisture content 0.20 1 0.203 1.561 0.2159
D-Incubation period 0.01 1 0.010 0.078 0.7814
AB 3.09 1 3.088 23.729 <0.0001
AC 0.79 1 0.795 6.108 0.0161
BC 0.49 1 0.487 3.742 0.0574
BD 0.37 1 0.368 2.828 0.0974
CD 0.47 1 0.474 3.644 0.0607
A2 20.28 1 20.280 155.834 <0.0001
B2 6.81 1 6.813 52.350 <0.0001
C2 9.79 1 9.793 75.250 <0.0001
Residual 8.46 65 0.130
Lack of fit 8.13 12 0.678 109.375 <0.0001
Pure error 0.33 53 0.006
Cor total 65.43 77
* Values of ‘‘Prob > F” less than 0.05 indicate model terms are significant.
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Table 4 Central composite design runs with actual and predicted response values.
Run number Lovastatin mg/g Run number Lovastatin mg/g
Actual value Predicted value Residuals Actual value Predicted value Residuals
1 2.956 2.499 0.457 40 0.950 1.050 0.100
2 2.975 2.499 0.476 41 0.943 1.050 0.107
3 2.944 2.499 0.445 42 0.931 1.050 0.119
4 1.169 1.204 0.035 43 1.723 1.730 0.007
5 1.069 1.204 0.135 44 1.775 1.730 0.045
6 1.175 1.204 0.029 45 1.784 1.730 0.054
7 1.506 1.317 0.189 46 1.125 0.935 0.190
8 1.536 1.317 0.219 47 1.131 0.935 0.196
9 1.544 1.317 0.227 48 1.119 0.935 0.184
10 1.144 1.036 0.108 49 0.769 1.767 0.998
11 1.125 1.036 0.089 50 0.845 1.767 0.922
12 1.103 1.036 0.067 51 0.875 1.767 0.892
13 2.972 2.860 0.112 52 0.000 0.323 0.323
14 3.018 2.860 0.158 53 0.000 0.323 0.323
15 2.806 2.860 0.054 54 0.000 0.323 0.323
16 1.191 1.050 0.141 55 1.931 2.303 0.372
17 1.141 1.050 0.091 56 2.034 2.303 0.269
18 1.163 1.050 0.113 57 2.063 2.303 0.240
19 2.750 2.080 0.670 58 0.886 1.005 0.119
20 2.688 2.080 0.608 59 0.288 1.005 0.717
21 2.662 2.080 0.582 60 0.880 1.005 0.125
22 0.919 1.285 0.366 61 0.884 1.292 0.408
23 1.031 1.285 0.254 62 0.891 1.292 0.401
24 0.969 1.285 0.316 63 0.882 1.292 0.410
25 3.188 2.897 0.291 64 1.288 1.504 0.216
26 3.156 2.897 0.259 65 1.306 1.504 0.198
27 3.175 2.897 0.278 66 1.297 1.504 0.207
28 1.675 1.601 0.074 67 2.731 2.915 0.184
29 1.625 1.601 0.024 68 2.756 2.915 0.159
30 1.594 1.601 0.007 69 2.746 2.915 0.169
31 1.753 1.364 0.389 70 2.719 2.963 0.244
32 1.731 1.364 0.367 71 2.756 2.963 0.207
33 1.794 1.364 0.430 72 2.781 2.963 0.182
34 1.150 1.083 0.067 73 2.750 2.939 0.189
35 1.125 1.083 0.042 74 2.875 2.939 0.064
36 1.069 1.083 0.014 75 2.843 2.939 0.096
37 3.256 2.860 0.396 76 2.844 2.939 0.095
38 3.238 2.860 0.378 77 2.813 2.939 0.126
39 3.353 2.860 0.493 78 2.813 2.939 0.126
Figure 3 3D plots of the effect of different factors and factors interactions on lovastatin production by Aspergillus fumigatus under SSF.
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258 F.E. Mouafi et al.respectively. While, groundnut shells; beet peel; rice hulls and
pea pods showed low production of lovastatin 1.94; 1.75; 1.75
and1.13 mg/g dry fermented matter, respectively by Rhizopus
oligosporus. These results are in accordance with [17]. Based
on the results of the screening study, it is clear that, Aspergillus
fumigatus has the greatest affinity to produce lovastatin using
wheat bran (2.84 mg/g). As wheat bran fermentation with A.
fumigatus produces maximum yield of lovastatin, wheat bran
was selected as suitable substrate for further optimization
study with A. fumigatus under solid state fermentation using
response surface methodology.
3.2. Identification of the potent lovastatin producing fungus
isolate
Fungal colonies produce thousands of minute gray-green coni-
dia (2–3 lm). The fungus can grow at 37 C, up to 50 C tem-
peratures. The morphological and conidial features in the
culture growth and DNA partial sequencing showed that the
most potent lovastatin producing fungal isolate is Aspergillus
fumigatus. The phylogenetic relationship of Aspergillus fumiga-
tus within representative species of the genus Aspergillus is
shown in Fig. 2.
After running the CCD, the experimental results were sta-
tistically analyzed using analysis of variance (ANOVA). The
results of ANOVA are shown in Table 3.
The Model F-value of 36.48 implies the model is significant
and there is only a 0.01% chance that a ‘‘Model F-Value” this
large could occur due to noise. The model showed that A, B,
AB, AC, A2, B2, C2 are significant model terms. The ‘‘Lack
of Fit F-value” of 109.37 implies the Lack of Fit is significant
and there is only a 0.01% chance that a ‘‘Lack of Fit F-value”
this large could occur due to noise.
The ‘‘Predicted R-Squared” of 0.8072 is in reasonable
agreement with the ‘‘Adjusted R-Squared” of 0.8468. The ade-
quate Precision – measures the signal to noise ratio and a ratio
greater than 4 is desirable – equals to 22.313 which indicates an
adequate signal. The R2 value of 0.8707 indicates that the
model is reliable. Accordingly, this model can be used to nav-
igate the lovastatin design space. The interactions between fac-
tors are shown in the following figures. The actual and
predicted results of the model runs are shown in Table 4 based
on the final equation of the model shown below (see Fig. 3).
3.3. Final equation in terms of actual factors
Lovastatin (mg/g) = 45.94002 + (1.89923 * Temperature)
+ (1.16020 * pH) + (0.53989 * Moisture content) +
(0.37787 * Incubation period) + (0.063411 * Tempera-
ture * pH)  (3.21719E003 * Temperature * Moisture con-
tent) + (0.010073 *pH * Moisture content)  (0.029188
* pH * Incubation period)  (3.31319E003 * Moisture con-
tent * Incubation period)  (0.034645 * (Temperature)2) 
(0.32129 * (pH)2)  (3.85203E003 * (Moisture content)2).
Response Surface Methodology (RSM) approach has been
well adopted to assess lovastatin yield and determine the opti-
mum fermentation parameters [24]. Maximum lovastatin yield
(3.353 mg/g) was recorded at pH 5.0. This result is in accor-
dance with [2] also, Valera et al. [26] and Atalla [1] indicated
that, increase in pH resulted in a gradual decrease in lovastatinproduction due to the denaturation or inactivation of the
microbial strain, because pH strongly influences the transport
of various components across the cell membrane which sup-
port the cell growth and product formation. Maximum lovas-
tatin yield was at a temperature of 28 C this result falls in line
with [17,15] where, further increase in temperature, more heat
is accumulated, leads to poor heat dissipation and reduces the
oxygen level, thereby reducing the growth of microorganism.
The maximum lovastatin yield was achieved at 12 days of fer-
mentation period, this result is in accordance with [20]. On the
other hand, maximum lovastatin yield was achieved at initial
moisture content (70 v/w). As the moisture content increases,
the air in fermentation medium decreases, resulting in poor
oxygen availability [26,17] Also, an increase or a decrease in
moisture content affected the oxygen and water balance [14],
thereby decreasing lovastatin yield. The higher lovastatin yield
associated with solid state fermentation (SSF) [25] is due to
increased mycelial density [21]; and increased porosity [18].
Also, it involves lower media and product cost.
4. Conclusion
The current investigation was mainly focused on the screening
of various fungal species for lovastatin production utilizing dif-
ferent agro-based wastes under solid state fermentation. The
isolated fungus Aspergillus fumigatus showed the maximum
yield of lovastatin. As optimum conditions of lovastatin pro-
duction by Aspergillus fumigatus using wheat bran have been
attained efficiently by response surface methodology (RSM),
the Lovastatin yield (3.353 mg/g dry fermented matter) was
achieved with the following optimized culture conditions
(temp. of 28 C; pH of 5.00; initial moisture content of 70%
and incubation period of 12 days). The feasibility of solid state
fermentation (SSF) as a promising technique in exploiting
cheaply available agro-residual and employing response sur-
face methodology (RSM) as an optimization technique not
only increases the yield but also results in economic lovastatin
production.
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